Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001201522 | SCV001372596 | uncertain significance | Interstitial lung and liver disease; Charcot-Marie-Tooth disease, axonal, type 2u | 2019-07-31 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val33*) in the MARS gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs773474721, ExAC 0.009%). This variant has not been reported in the literature in individuals with MARS-related conditions. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MARS cause disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |